J. Menzies

发表

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

J. Hutcheon, L. Magee, M. Merialdi, 2011, The Lancet.

Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial

J. Singer, A. Gafni, A. Logan, 2016, Acta obstetricia et gynecologica Scandinavica.

Less-tight versus tight control of hypertension in pregnancy.

J. Singer, A. Gafni, A. Logan, 2015, The New England journal of medicine.

Evidence-based management for preeclampsia.

L. Magee, P. von Dadelszen, D. Sawchuck, 2007, Frontiers in bioscience : a journal and virtual library.

The PIERS experience: research or quality improvement?

L. Magee, B. Payne, P. von Dadelszen, 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Current CHS and NHBPEP Criteria for Severe Preeclampsia Do Not Uniformly Predict Adverse Maternal or Perinatal Outcomes

Y. MacNab, L. Magee, J. Ansermino, 2007, Hypertension in pregnancy.

The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study)

J. Singer, A. Gafni, A. Logan, 2016, Hypertension.

The CHIPS

A. Gafni, L. Magee, E. Asztalos, 2016 .

T the Chips Randomized Controlled Trial (control of Hypertension in Pregnancy Study) Is Severe Hypertension Just an Elevated Blood Pressure?

J. Singer, A. Gafni, A. Logan, 2022 .

Instituting Surveillance Guidelines and Adverse Outcomes in Preeclampsia

Y. MacNab, L. Magee, H. Stuart, 2007, Obstetrics and gynecology.

Predicting adverse outcomes in women with severe pre-eclampsia.

L. Magee, B. Payne, P. von Dadelszen, 2009, Seminars in perinatology.

The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial)

J. Singer, A. Gafni, A. Logan, 2016, Hypertension.

The complications of hypertension in pregnancy.

L. Magee, P. von Dadelszen, J. Menzies, 2005, Minerva medica.

PIERS proteinuria: relationship with adverse maternal and perinatal outcome.

Z. Bhutta, A. Nakimuli, K. Joseph, 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

The PIERS (Pre-eclampsia Integrated Estimate of RiSk) model : development of a valid outcome prediction model for pre-eclampsia.

J. Menzies, 2009 .

Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial

J. Singer, A. Gafni, G. Koren, 2016, BJOG : an international journal of obstetrics and gynaecology.

Predicting adverse outcomes in women with severe pre-eclampsia.

L. Magee, B. Payne, P. von Dadelszen, 2009, Seminars in perinatology.

Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study).

J. Singer, A. Gafni, A. Logan, 2016, European journal of obstetrics, gynecology, and reproductive biology.

Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study

Z. Bhutta, A. Nakimuli, D. Dunsmuir, 2024, The Lancet. Digital health.